695 related articles for article (PubMed ID: 1019166)
1. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
2. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
Higuma K; Fujishima S; Shionoiri H; Tochikubo O; Uneda S; Fujiki Y; Kaneko Y
Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
[No Abstract] [Full Text] [Related]
4. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
[TBL] [Abstract][Full Text] [Related]
5. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
Mimran A; Shaldon S; Barjon P; Mion C
Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
[TBL] [Abstract][Full Text] [Related]
6. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
Nigawara K; Yagihashi Y; Kogawa T; Kawamata A; Yamaya K; Sugawara S; Tulachan Y; Funyu T; Eba H; Kido K; Tanaka T; Morita S; Fukushi M; Furusawa M; Terayama Y; Hirayama N
Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404
[No Abstract] [Full Text] [Related]
7. Effect of saralasin on plasma aldosterone in hypertensive man.
Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
[No Abstract] [Full Text] [Related]
8. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
Fagard R; Lijnen P; Amery A; Reybrouck T
Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
[TBL] [Abstract][Full Text] [Related]
9. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
[No Abstract] [Full Text] [Related]
10. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?
Davies DL; Beevers DG; Brown JJ; Cumming AM; Fraser R; Lever AF; Mason PA; Morton JJ; Robertson JI; Titterington M; Tree M
J Endocrinol; 1979 May; 81(2):79P-91P. PubMed ID: 458346
[No Abstract] [Full Text] [Related]
12. Effect of an angiotensin II analogue upon blood pressure, plasma renin concentration and plasma aldosterone in hypertensive patients.
Vierhapper H; Waldhäusl W
Arzneimittelforschung; 1979; 29(8):1175-7. PubMed ID: 583019
[TBL] [Abstract][Full Text] [Related]
13. [Saralasin in subjects with low renin arterial hypertension].
Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
[TBL] [Abstract][Full Text] [Related]
14. Effect of adrenal arterial infusion of saralasin (P113) on aldosterone secretion.
Blair-West JR; Coghlan JP; Denton DA; Niall HD; Scoggins BA; Tregear GW
Prog Biochem Pharmacol; 1976; 12():53-62. PubMed ID: 1019170
[TBL] [Abstract][Full Text] [Related]
15. The effect of high sodium intake and angiotensin antagonist in rabbits with severe and moderate hypertension induced by constriction of one renal artery.
Romero JC; Holmes DR; Strong CG
Circ Res; 1977 May; 40(5 Suppl 1):I17-23. PubMed ID: 870227
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the angiotensin antagonist saralasin (1-sar-8-ala-angiotensin II) on the blood pressure in secondary hypertension].
Beckerhoff R; Vetter W; Furrer J; Tuma J; Zàruba K; Vetter H; Siegenthaler W
Schweiz Med Wochenschr; 1976 Dec; 106(49):1738-41. PubMed ID: 1013696
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
Brunner HR; Gavras H; Ribeiro AB; Posternak L
Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of angiotensin antagonists.
Pettinger WA; Mitchell HC
Fed Proc; 1976 Nov; 35(13):2521-5. PubMed ID: 976494
[TBL] [Abstract][Full Text] [Related]
19. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
[TBL] [Abstract][Full Text] [Related]
20. Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys.
Linas SL; Miller PD; McDonald KM; Stables DP; Katz F; Weil R; Schrier RW
N Engl J Med; 1978 Jun; 298(26):1440-4. PubMed ID: 349389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
